GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alivus Life Sciences Ltd (BOM:543322) » Definitions » 3-Year Dividend Growth Rate

Alivus Life Sciences (BOM:543322) 3-Year Dividend Growth Rate : 0.00% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Alivus Life Sciences 3-Year Dividend Growth Rate?

Alivus Life Sciences's Dividends per Share for the three months ended in Dec. 2024 was ₹0.00.

The historical rank and industry rank for Alivus Life Sciences's 3-Year Dividend Growth Rate or its related term are showing as below:

BOM:543322's 3-Year Dividend Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 11.45
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

During the past 12 months, Alivus Life Sciences's average Dividends Per Share Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Alivus Life Sciences's Dividend Payout Ratio for the three months ended in Dec. 2024 was 0.00. As of today, Alivus Life Sciences's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Alivus Life Sciences's 3-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Alivus Life Sciences's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alivus Life Sciences's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alivus Life Sciences's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Alivus Life Sciences's 3-Year Dividend Growth Rate falls into.


;
;

Alivus Life Sciences 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Alivus Life Sciences  (BOM:543322) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Alivus Life Sciences's Dividend Payout Ratio for the quarter that ended in Dec. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2024 )/ EPS without NRI (Q: Dec. 2024 )
=0/ 11.14
=0.00

During the past 6 years, the highest Dividend Payout Ratio of Alivus Life Sciences was 0.83. The lowest was 0.29. And the median was 0.59.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 6 years, the highest Dividend Yield of Alivus Life Sciences was 8.04%. The lowest was 0.00%. And the median was 2.71%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alivus Life Sciences 3-Year Dividend Growth Rate Related Terms>


Alivus Life Sciences Business Description

Traded in Other Exchanges
Address
470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400 099
Alivus Life Sciences Ltd, formerly Glenmark Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disease, pain management, diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.

Alivus Life Sciences Headlines

No Headlines